Democrats’ major drug pricing reforms clear a hurdle in the House
The House advanced Dems’ drug pricing reforms, including cost caps for insulin and permission for Medicare to negotiate some drug prices.
Read The StoryPolitics
Tracking how politics and policy influence health care and medicine. To get the latest delivered to your inbox, sign up for our free D.C. Diagnosis newsletter. And subscribe to STAT+ for inside intelligence on the intersection of Capitol Hill and the life sciences.
All Coverage
advertisement
